Neoadjuvant Systemic Therapy in Breast Cancer
A prospective, multicentre national audit Neoadjuvant systemic therapy is increasingly used in the treatment of breast cancer, and has advantages over
traditional chemotherapy scheduling:
• Downstaging of disease to allow breast conserving surgery
• Early administration of systemic treatment
• Allows tailoring of further treatment using information about
response to neoadjuvant therapy
Access to neoadjuvant systemic therapies is extremely variable. There are no current guidelines on best practice in this area in the United Kingdom, and no consensus on the surgical management of either the breast or axilla in patients following neoadjuvant treatment
NeST is a prospective national multicentre audit with two stages:
• Stage 1 – National Practice Survey
• Stage 2 – National Prospective Audit
The study aims to:
• Establish current practice and determine indications for use
• Explore associated surgical management
• Determine practice in the monitoring and reporting of response
• Establish treatment response rates in a real-world setting
Open to all breast units in the U.K. Data collection commencing December 2017.
For further information see:
Associate Surgical Specialty Lead
The RCS Surgical Trials Initiative was launched in 2012, and has appointed Surgical Specialty Lead across most specialties. One of the over-riding aims of the Initiative is to develop trainee involvement in surgical research. The role of Associate SSL in Breast Surgery provides the unique opportunity for a breast surgery trainee to work with the SSL to develop and deliver surgical research within breast surgery, and applications for this role are now invited.
More information, and a description of the role, are available by contacting the SSL for Breast Surgery, Mr. Stuart McIntosh, at email@example.com
If you wish to apply for this role, then please send Mr McIntosh (at the email address above, by February 16th) a current CV together with a short (maximum one page A4) summary outlining:
• Why you would like to be considered for the role
• Your research interests and research experience to date
• What you would hope to gain from the post
Mammary Fold Academic Committee (MFAC) membership application
In 2014, the Mammary Fold Academic Collaborative (MFAC) was formed with the aim of promoting trainee-led audit and research at a national level. We are looking for a dynamic, motivated and inspiring trainees to join the MFAC.
The post involves participation at the MFAC telephone conferences/meetings and supporting research activities endorsed by MFAC. In addition, the role may involve representing the trainees at the quarterly ABS Academic and Research Committee meetings and acting as a link between the groups. This is an excellent opportunity to improve the networks within groups interested in breast surgery research. As an MFAC member you will play a vital role in supporting trainee-led collaborative & other studies in breast disease. Furthermore, the role will involve organising & attending the annual Mammary Fold Academic and Research meeting, which has been successful in showcasing trainee-led collaborative studies in breast disease.
Clinical Fellow in Breast Surgery
Frimley Health NHS Foundation Trust
Department: Breast Surgery
Location: Frimley Park Hospital, GU16 7UJ, Frimley
Salary:£35,093 - £48,123 pa plus